Vasodilator vs Placebo or no active treatment
Maximal mouth opening (interincisal distance) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)
It is very uncertain whether vasodilators (isoxsuprine, xanthinol nicotinate) changes maximal mouth opening (interincisal distance) compared with placebo or no active treatment (very low certainty).
2 findings from 1 review
- MD 4.04 [-1.93, 10.02]2 studies · 85 participantsVery low
- MD 2.51 [-0.99, 6.01]2 studies · 85 participantsVery low